Stocks and Investing
Stocks and Investing
Mon, September 13, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, September 10, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tiago Fauth Maintained (APLS) at Hold with Decreased Target to $38 on, Sep 10th, 2021
Tiago Fauth of Credit Suisse, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Decreased Target from $50 to $38 on, Sep 10th, 2021.
Tiago has made no other calls on APLS in the last 4 months.
There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Tiago
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $74 on, Thursday, August 19th, 2021
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $102 on, Tuesday, August 10th, 2021
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $101 on, Friday, July 2nd, 2021
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $82 on, Friday, May 21st, 2021
Contributing Sources